… The most effective pharmacotherapies for opiate use disorders are … in medication
development for other substance use disorders such as stimulant addiction. The role of medication …

… Introduction: Substance use disorders are a group of chronic relapsing disorders of the brain…
First, increasing amount of prescriptions for certain medications for opioid use disorders (eg …

… agencies to arrive at meaningful outcomes for medication approval and 3) a greater
involvement of the healthcare system in the screening and treatment of substance use disorders. …

… extended-release naltrexone, the three medications approved by the Food and Drug … use
disorder. Yet only a minority of people with opioid use disorders receive any substance use …

… , yet controversy remains regarding potential iatrogenic effects of stimulant medication,
particularly with respect to increasing susceptibility to later substance use disorders. However, …

… on the clinical development of medications that directly target … -use disorders and, more
recently, cannabis-use disorder. … medications to reduce reinforcing effects and substance-use …

The use of medications to treat substance use disorders (SUDs) has emerged as a potentially
central part of the treatment armamentarium. In this paper we present data from several …

… of psychiatric and substance use disorders. Between April and … disorders, psychotic disorders,
and substance use disorders. We … -deficit hyperactivity disorder (ADHD), bipolar disorder, …

… and opportunities to develop medications to treat substance use disorders (SUDs), a … to
study new medications. It also provides information about medications currently investigated with …

… in the development of medications to treat substance use disorders (SUDs) is modest,
particularly when compared to the societal costs created by these disorders. For example, more …